Pricing Log in Create free account

DBV Technologies S.A. (DBVT) vs Design Therapeutics, Inc. (DSGN)

DBV Technologies S.A. and Design Therapeutics, Inc. are both Biotechnology companies. DBV Technologies S.A. and Design Therapeutics, Inc. are of similar size ($615.8M and $605.2M). Design Therapeutics, Inc. has the higher net margin (0.00% vs −5,547.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Design Therapeutics, Inc. leads on 10 and DBV Technologies S.A. on 5.

Valuation

Metric DBVT DSGN Biotechnology median
P/E n/m n/m 10.60
P/S 255.21 2,842.20 9.40
P/B 6.42 3.18 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 210.91 1,919.15 9.02
Earnings yield (29.23%) (11.79%) (32.88%)
Free cash flow yield (20.11%) (9.24%) (23.13%)

Profitability

Metric DBVT DSGN Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (5,571.63%) 0.00% 0.00%
Net margin (5,547.30%) 0.00% 0.00%
Free cash flow margin (5,131.50%) 0.00% 0.00%
Return on equity (205.75%) (36.87%) (51.96%)
Return on assets (127.19%) (34.57%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DBVT DSGN Biotechnology median
Revenue growth (TTM) (33.42%) — 6.76%
EPS growth (last fiscal year) 10.26% (38.64%) 29.88%
Revenue growth, 5-year CAGR (12.95%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DBVT DSGN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.24 16.78 4.97
Net debt to EBITDA 1.35 2.68 1.01

Dividend

Metric DBVT DSGN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DBVT DSGN Biotechnology median
Market cap 615.83m 605.16m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack